Aligos Therapeutics, Inc. (ALGS) vs DocGo Inc. (DCGO)
A side-by-side comparison of Aligos Therapeutics, Inc. and DocGo Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALGS
Aligos Therapeutics, Inc.
$5.37HealthcareDelayed quote: Oct 6, 2026, 12:17 PM EDT
DCGO
DocGo Inc.
$0.36HealthcareDelayed quote: Oct 6, 2026, 12:24 PM EDT
Total return — ALGS vs DCGO
growth of $100 · dividends reinvested · last 6yALGS -99.1% (-54.4%/yr)DCGO -96.5% (-42.7%/yr)DCGO compounded faster over this window
ALGS DCGO
ALGS vs DCGO: by the numbers
- •DCGO is the larger company ($36M vs $33M market cap).
- •Both run net losses; DCGO's is the smaller (-65.29% vs -241.01% net margin).
- •DCGO grew revenue faster over the past five years (11.63% vs -15.85% CAGR).
Metrics side by side
Valuation
| Metric | ALGS | DCGO |
|---|---|---|
| P/S ratio | 1.05 | 0.12 |
| P/B ratio | 1.04 | 0.30 |
Profitability
| Metric | ALGS | DCGO |
|---|---|---|
| Gross margin | 57.46% | 30.12% |
| Operating margin | -4024.93% | -27.67% |
| Net margin | -241.01% | -65.29% |
| ROE | -238.24% | -161.63% |
| ROIC | -207.97% | -89.44% |
Growth (annualized)
| Metric | ALGS | DCGO |
|---|---|---|
| Revenue CAGR (5Y) | -15.85% | 11.63% |
| Total return CAGR (5Y) | -57.15% | -48.40% |
Frequently asked
- Which has grown faster, ALGS or DCGO?
- Over the past five years, DCGO grew revenue faster — ALGS at a -15.85% CAGR versus DCGO at 11.63%.
- How have ALGS and DCGO total returns compared?
- Over the past 5 years, ALGS delivered -57.15% and DCGO delivered -48.40% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.